Edition:
United Kingdom

Abeona Therapeutics Inc (ABEO.OQ)

ABEO.OQ on NASDAQ Stock Exchange Capital Market

1.83USD
23 Aug 2019
Change (% chg)

$-0.21 (-10.29%)
Prev Close
$2.04
Open
$2.03
Day's High
$2.07
Day's Low
$1.82
Volume
121,700
Avg. Vol
156,378
52-wk High
$15.60
52-wk Low
$1.82

About

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)

Overall

Beta: 1.79
Market Cap(Mil.): $147.49
Shares Outstanding(Mil.): 49.16
Dividend: --
Yield (%): --

Financials

  ABEO.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -1.36 -- --
ROI: -41.22 7.52 12.69
ROE: -45.09 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates